Management and Updates of Medullary Thyroid Cancer

While medullary thyroid cancer remains a surgically treated malignancy, the opportunity for cure is dependent on early diagnosis and treatment. After a brief review of current treatment guidelines, panelists and moderator, Susan Mandel, MD, participate in a semi-structured case-based discussion of disease management focusing on areas of critical importance to management and those that remain controversial.

This panel discussion of specialists from across the Penn Medicine health system include endocrinology, pathology and laboratory, medical oncology and surgical oncology discusses Medullary Thyroid Cancer in the context of diagnosis, surgical management, surveillance and systemic therapy indications, and research—including the new MTC CAR-T Clinical Trial.

Related Links:

Enrolling Now: A CAR-T Trial for Medullary Thyroid Cancer
Annual Updates in Management of Thyroid Nodules
Management of High Risk Thyroid Cancer
See Dr. Kelz's physician profile
See Dr. LiVolsi's physician profile
See Dr. Mandel's physician profile
See Dr. Nathanson's physician profile
See Dr. Sun's physician profile



Related Videos